Literature DB >> 23715784

Rational use of antihypertensive medications in children.

Michael A Ferguson1, Joseph T Flynn.   

Abstract

Hypertension has traditionally been regarded as an uncommon diagnosis in childhood and adolescence; however, there is compelling evidence to suggest that its prevalence is on the rise, particularly in those with obesity. As a result, pediatricians increasingly are asked to evaluate and manage patients with elevated blood pressure. An increased emphasis on conducting drug trials in children over the last 15 years has yielded important advances with respect to evidence-based data regarding the efficacy and safety of antihypertensive medications in children and adolescents. Unfortunately, data to definitively guide selection of initial agents is lacking. This article will present guidelines for the appropriate use of antihypertensive medications in the pediatric population, including the rational approach to selecting an appropriate medication with respect to pathophysiology, putative benefit, and likelihood for side effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23715784     DOI: 10.1007/s00467-013-2510-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  75 in total

1.  Does it matter how blood pressure is lowered in patients with metabolic risk factors?

Authors:  Arya M Sharma
Journal:  J Am Soc Hypertens       Date:  2008 Jul-Aug

2.  Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study.

Authors:  Franz Schaefer; Mieczyslaw Litwin; Jacek Zachwieja; Aleksandra Zurowska; Sandor Turi; Amie Grosso; Nicole Pezous; Mahomed Kadwa
Journal:  J Hypertens       Date:  2011-12       Impact factor: 4.844

3.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

4.  Strict blood-pressure control and progression of renal failure in children.

Authors:  Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

5.  Underweight and overweight among children and adolescents in Tuscany (Italy). Prevalence and short-term trends.

Authors:  G Lazzeri; S Rossi; A Pammolli; V Pilato; T Pozzi; M V Giacchi
Journal:  J Prev Med Hyg       Date:  2008-03

6.  Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.

Authors:  Brent M Egan; Jan N Basile; Shakaib U Rehman; Phillip B Davis; Curt H Grob; Jessica Flynn Riehle; Christine A Walters; Daniel T Lackland; Carmen Merali; Jean E Sealey; John H Laragh
Journal:  Am J Hypertens       Date:  2009-04-16       Impact factor: 2.689

7.  Trends in blood pressure among children and adolescents.

Authors:  Paul Muntner; Jiang He; Jeffrey A Cutler; Rachel P Wildman; Paul K Whelton
Journal:  JAMA       Date:  2004-05-05       Impact factor: 56.272

8.  Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study.

Authors:  Joseph T Flynn; Mark Mitsnefes; Christopher Pierce; Steven R Cole; Rulan S Parekh; Susan L Furth; Bradley A Warady
Journal:  Hypertension       Date:  2008-08-25       Impact factor: 10.190

9.  The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).

Authors:  Kazutoshi Murakami; Jun Wada; Daisuke Ogawa; Chikage Sato Horiguchi; Tomoko Miyoshi; Motofumi Sasaki; Haruhito A Uchida; Yoshio Nakamura; Hirofumi Makino
Journal:  Diab Vasc Dis Res       Date:  2012-05-04       Impact factor: 3.291

10.  Prevalence of childhood obesity in Spain: National Health Survey 2006-2007.

Authors:  J Valdés Pizarro; M A Royo-Bordonada
Journal:  Nutr Hosp       Date:  2012 Jan-Feb       Impact factor: 1.057

View more
  10 in total

Review 1.  Management of Hypertension in Children and Adolescents.

Authors:  Joshua Samuels; Cynthia Bell; Joyce Samuel; Rita Swinford
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

Review 2.  Impact of obesity on kidney function and blood pressure in children.

Authors:  Wei Ding; Wai W Cheung; Robert H Mak
Journal:  World J Nephrol       Date:  2015-05-06

Review 3.  Treatment of hypertension in children with chronic kidney disease.

Authors:  Susan Halbach; Joseph Flynn
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

4.  Description of Antihypertensive Medication Use in a Pediatric Practice: Single and Multiple Antihypertensive Medication Therapy.

Authors:  Edem Binka; Susan Mendley; Peter Gaskin; Carisa Himes; Laide Jinadu; Carissa M Baker-Smith
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-02       Impact factor: 3.738

5.  Pediatric Obesity, Hypertension, Lipids.

Authors:  Scott Leopold; Justin P Zachariah
Journal:  Curr Treat Options Pediatr       Date:  2020-04-15

6.  Participation of hypertension patients in early-phase clinical trials.

Authors:  Paul Borron; Oren Cohen; Theo J Hoofwijk; J Rick Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-22       Impact factor: 3.738

Review 7.  Evaluation and treatment of hypertensive crises in children.

Authors:  Deborah R Stein; Michael A Ferguson
Journal:  Integr Blood Press Control       Date:  2016-03-16

8.  Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults.

Authors:  Nicholas J A Webb; Thomas Wells; Max Tsai; Zhen Zhao; Attila Juhasz; Caroline Dudkowski
Journal:  Eur J Clin Pharmacol       Date:  2016-01-04       Impact factor: 2.953

9.  7th Brazilian Guideline of Arterial Hypertension: Chapter 10 - Hypertension in Children and Adolescents

Authors:  M V B Malachias; V Koch; Colombo Colombo; Silva Silva; I C B Guimarães; P K Nogueira
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000

Review 10.  Treatment strategies to prevent renal damage in hypertensive children.

Authors:  Piotr Czarniak; Aleksandra Zurowska
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.